Targeted therapies—treatments that zero in on cancerous cells—are among the current treatments for fighting cancer. One type of targeted therapy, monoclonal antibodies, has made great progress in recent years. Find out how scientists developed these treatments and how they can offer new hope to people with cancer.
Keywords: Non Hodgkin's Lymphoma, Lymphoma, gilda's club, Zevalin, monoclonal antibodies, immune system, HAMA, chemotherapy, Rituxan, CHOP, radioimmunotherapy, CD20 antigen, targeted therapies, NHL, mouse antibodies, malignant cells, targeted therapy, rituximab, Herceptin, CamPath, chronic lymphocytic leukemia, human anti-mouse antibodies, Mab
As with any disease, the accurate diagnosis of Lymphoma is crucial to providing the best, most effective treatment for each individual patient. So while new medications and treatment strategies get a lot of attention, advances in diagnostic technologies are also exciting and important. At the 42nd annual meeting of the American Society of Hematology in December, there was a lot of talk about something called a gene chip -- or DNA microarray analysis -- which has recently been used to diagnose Diffuse Large B-Cell Lymphoma. What is a gene chip and how does it work? How will it lead to more effective treatments? Our panel of experts will include Margaret Shipp, MD, who presented on this topic at the conference.
Keywords: lymphoma, non hodgkins lymphoma, nonhodgkins lymphoma, burkitts lymphoma, lymphoma symptoms, hodgkinslymphoma, mantle cell lymphoma, burkitt's lymphoma, lymphoma cancer, lymphoma types, nonhodgkin's lymphoma, lymphoma treatment, large cell lymphoma, nonhodgkin's lymphoma treatment, b cell lymphoma, indolent lymphoma, cutaneous lymphoma, leukemia and lymphoma
Targeted therapies, those that hone in on cancer cells, are the latest weapons used in the treatment of non-Hodgkin's lymphoma. Learn about the different targeted therapies available and how they are selected.
Keywords: targeted therapies, non-Hodgkin's lymphoma, NHL, lymphoma, cancer, Rituxan, rituximab, chemotherapy, radioimmunotherapy, radiation therapy, monoclonal antibodies, MAB's, Zevalin, Bexxar, ibritumomab, tositumomab, I-131, yttrium, bone marrow transplantation, stem cell transplant, cancer side effects, targeted therapy
Vaccines for cancer are no longer futuristic medicine. See how people with non-Hodgkin's lymphoma are on the cutting edge of research.
Keywords: Cancer, lymph glands, lymphoma, non-Hodgkin's lymphoma, NHL, antibody, antibodies, slow-growing NHL, low-grade lymphoma, high grade lymphoma, indolent NHL, aggressive NHL, follicular NHL, follicular non-Hodgkin's lymphoma, immunotherapy, customized immunotherapy, passive immunotherapy, active immunotherapy, B cell lymphoma, T cell lymphomas, immune system, tumor, biopsy, idiotype, vaccine, chemotherapy, radiation therapy, Rituxan, Rituximab fludara, fludarabine, Herceptin, trastuzumab, Zevalin, Ibritumomab, Tiuxetan, Bexxar, Tositumomab, Phase I trials, Phase II trials, Phase III trials, bone marrow biopsy, CT scans, Genitope, National Cancer Institute
Doctors are using drugs that mimic the natural immune response to help fight non-Hodgkin's lymphoma. Learn how these new treatments work.
Keywords: monoclonal antibodies, monoclonal antibody, Rituxan, retuximab, ibritumomab, Zevalin, tositumomab, Bexxar, non Hodgkins lymphoma, non-Hodgkins lymphoma, non Hodgkin's lymphoma,
Non-Hodgkin's lymphoma is the sixth most frequent cancer. It affects the cells of the immune system that should be protecting the body against disease. Listen to experts discuss the ABCs of NHL.
Keywords: Lymphoma, Non-Hodgkin's lymphoma, NHL, Hodgkin's lymphoma, immune system, tumor, lymph nodes, spleen, bone marrow, lymph glands, glands, indolent lymphoma, aggressive lymphoma, slow-growing lymphoma, chemotherapy, radiation treatments, radiation, radiotherapy, immune therapy, immunotherapy, radioactive antibody, antibody, active immune therapy, passive immune therapy, passive immunotherapy, active immunotherapy, Hodgkins
Every year, the Lymphoma Research Foundation hosts a forum for people living with lymphoma and the healthcare professionals that care for them. People attending this weekend gathering exchange latest news about treatment and discuss issues important to people living with lymphoma. See highlights from featured speakers in excerpts from the 2002 Lymphoma Forum.
Keywords: lymphoma, non-Hodgkin's lymphoma, NHL, follicular lymphoma, cancer vaccine, BCL-2 antisense oligonucleotide, rituxan, rituximab, CHOP, B cell lymphoma, radioimmunotherapy, antibody, radiation, CLL, Hodgkin's disease, bone marrow transplantation, Bexxar, Zevalin
Fighting non-Hodgkin's lymphoma (NHL) can be a tough battle. Eileen Merle-Rao is a person with NHL who tried two different rounds of therapies, which ultimately failed her. Then her doctors suggested a unique form of radiation therapy called radioimmunotherapy. The best news is that Eileen has seen a marked improvement in her disease and now is looking forward to a future filled with possibility.
Keywords: Non-Hodgkin's Lymphoma, NHL, Lymphoma, Hodgkin's disease, Hodgkin's disease, cancer, tumor, radioimmunotherapy, targeted therapy, chemotherapy, immune system, antibodies, monoclonal antibodies, radioactive antibodies, radiation, cold antibody, unlabeled antibody, hot antibody, labeled antibody, radiolabeled antibody, complete remission, partial remission, partial response, complete response, unlabeled monoclonal antibody therapy, labeled monoclonal antibody therapy, low blood counts, myleosuppresion, neuropathy, antibody targeted treatments, cancer treatment, Zevalin, Ibritumomab, Bexxar, Tositumomab
Monoclonal antibodies are improving treatment success for many people with aggressive forms of non-Hodgkin's lymphoma. How do they work?
Keywords: monoclonal antibodies, monoclonal antibody, Rituxan, retuximab, ibritumomab, Zevalin, tositumomab, Bexxar, non Hodgkins lymphoma, non-Hodgkin's lymphoma, non Hodgkin's lymphoma, non-Hodgkin's lymphoma, indolent lymphoma, CD20, anti CD20, b-cell lymphoma, diffuse, large B-cell lymphoma
Whether relapsed or refractory, tune in to learn about treatments for indolent non-Hodgkin's lymphoma.
Keywords: Radioimmunotherapy, non-Hodgkin's lymphoma, relapse, Indolent lymphoma, follicular lymphoma, Bexxar, Zevalin, remission, fludarabine, CHOP or CVP, monoclonal antibody,tumor, toxicity, long-term side effects
Learn how patients with indolent or slow-growing non-Hodgkin's lymphoma should go about picking the best treatment for themselves.
Keywords: A discussion of deciding among lymphoma treatment Options in Relapsed, Indolent Non-Hodgkin's Lymphoma
Data shows show that combining Rituxan and chemotherapy can have good results for patients with NHL. But does that mean that all patients will benefit from this strategy? Does adding chemotherapy to Rituxan bring small gains at the price of increased discomfort? Join us as we discuss these and other questions with experts from the American Society of Hematology 2001 meeting.
Keywords: rituxan, rituximab, combination therapy, lymphoma, b-cell lymphoma, chop, chemotherapy, chemo, non hodgkins lymphoma, non-hodgkins lymphoma, nhl, treatment, drugs, combo therapy, ash, american society of hematology meeting, meeting results, new trials
In recent years, the drug Rituxan has become a well-established option only for certain forms of non-Hodgkin's lymphoma (NHL) There are other types of NHL where Rituxan may be beneficial, but its effects on these cancers are not well known. Join us as we talk to experts about some exciting research in this area which was discussed at the 2001 American Society of Hematology meeting.
Keywords: Rituxan, rituximab, monoclonal antibody, targeted therapy, B-cell, B lymphocyte, cancer, autoimmune, blood disorder, anemia, hemophilia, ITP, TTP, immune thrombocytopenic purpura, thrombotic thrombocytopenic purpura, NHL, non-Hodgkin's lymphoma, B-cell autoimmune disorders, acquired hemolytic anemia, factor VIII
Vaccines have been powerful tools against infectious diseases. Learn how cancer researchers are now developing vaccines for non-Hodgkin's lymphoma.
Keywords: Cancer, lymph glands, lymphoma, non-Hodgkin's lymphoma, NHL, antibody, antibodies, slow-growing NHL, low-grade lymphoma, high-grade lymphoma, indolent NHL, aggressive NHL, follicular NHL, follicular non-Hodgkin's lymphoma, immunotherapy, customized immunotherapy, passive immunotherapy, active immunotherapy, B-cell lymphoma, T-cell lymphomas, immune system, tumor, biopsy, idiotype, vaccine, chemotherapy, Rituxan, Rituximab, fludara, fludarabine, Herceptin, trastuzumab, Zevalin, Ibritumomab, iuxetan, Bexxar, Tositumomab, cancer vaccine
Targeted therapies are not just for advanced cases non Hodgkin's lymphoma. Learn how they can help against indolent or low-grade cancers as well.
Keywords: monoclonal antibodies, monoclonal antibody, Rituxan, retuximab, ibritumomab, Zevalin, tositumomab, Bexxar, non Hodgkins lymphoma, non-Hodgkins lymphoma, non Hodgkin's lymphoma,
Doctors are finding that monoclonal antibodies can be helpful in the treatment of recurrent, indolent non-Hodgkin's lymphoma.
Keywords: monoclonal antibodies, monoclonal antibody, Rituxan, retuximab, ibritumomab, Zevalin, tositumomab, Bexxar, non Hodgkins lymphoma, non Hodgkin's lymphoma, indolent lymphoma, CD20, anti CD20, b-cell lymphoma
Since non-Hodgkin's Lymphoma can appear in many places in the body, it's often difficult to direct treatment to the specific cancer cells without causing harm to healthy tissue. Now doctors can deliver a lethal punch against NHL with a therapy that targets the cancer cells with radiation attached to antibodies that specifically seek out the cancer cells. Learn how this new weapon against NHL may help people with this disease.
Keywords: Non-Hodgkin's Lymphoma, NHL, Lymphoma, Hodgkin's disease, Hodgkin's disease, cancer, tumor, radioimmunotherapy, targeted therapy, chemotherapy, immune system, antibodies, monoclonal antibodies, radioactive antibodies, radiation, cold antibody, unlabeled antibody, hot antibody, labeled antibody, radiolabeled antibody, complete remission, partial remission, partial response, complete response, unlabeled monoclonal antibody therapy, labeled monoclonal antibody therapy, low blood counts, myleosuppresion, neuropathy, antibody targeted treatments, cancer treatment, Zevalin, Ibritumomab, Bexxar, Tositumomab
The newest strategy in the fight against cancer is harnessing the power of radiation by linking it to targeted drug therapy. Learn the precautions people must take and how these treatments are safely delivered to people with cancer.
Keywords: lymphoma, non-Hodgkin's lymhoma, gilda's club, B-cells, lymphocytes, radioimmunotherapy, antigen, Zevalin, ibritumomab, monoclonal antibody, MAB, Rituxan, Rituximab, radiation therapy, cancer therapy, targeted therapy, external beam radiation, radiation treatments, Bexxar, tositumomab
One of the newest treatments for non-Hodgkin's lymphoma is radioimmunotherapy, a clever mixture of old and new that better targets cancer cells.
Keywords: radioimmunotherapy, non-Hodgkin's, lymphoma, NHL, cancer, cells, monoclonal antibodies, immune system, radioactive, protein, CD20 antigen, B-cells, lymphocytes, radiation therapy, tumor, localized, targeted therapy, radiation, Zevalin, Bexxar, rituximab, fever, chills, fatigue, headaches, radioactivity
The aim of radiation therapy is to defeat cancer cells. Radiation can be delivered from a beam located outside the body, or by targeted medications called radioimmunotherapy. The choice of therapies will depend on the characteristics and type of tumor. Learn the differences between the conventional type of radiation and radioimmunotherapy.
Keywords: Non-Hodgkins Lymphoma, NHL, radiation therapy, radiation, antibodies, radioimmunotherapy, external beam radiation, conventional beam radiation, tumor, radioactive particles, antibody-targeted therapy, Zevalin, yytrium-90, Bexxar, I131, Rituxan, rituximab, ibritumomab, tositumomab, myelosuppression
Radiation can destroy cancer cells. People with cancers such as non-Hodgkin's lymphoma, now have new options that deliver this form of therapy in a very targeted way. A new treatment called radioimmunotherapy can deliver this radiation via medications, thereby targeting tumor cells wherever they are in the body. Learn about these novel medications and how they are being used today.
Keywords: Non-Hodgkins Lymphoma, Hodgkin's Lymphoma, NHL, radiation therapy, radiation, antibodies, monoclonal antibodies, isotopes, Iodine-131, Yttrium-90, beta radiation, gamma radiation, radioimmunotherapy, external beam radiation, conventional beam radiation, tumor, radioactive particles, antibody targeted therapy, Zevalin, Bexxar, Rituxan, rituximab, ibritumomab, tositumomab, myelosuppression, platelet count, white blood count, crossfire effect, nuclear medicine
Learn about new treatments available for patients with relapsed, indolent non-Hodgkin's lymphoma, as well as potential future treatments.
Keywords: Radioimmunotherapy, non-Hodgkin's lymphoma, relapse, Indolent lymphoma, follicular lymphoma, Bexxar, Zevalin, remission, fludarabine, monoclonal antibody, tumor, toxicity, stem cell transplant, cytokines, rituxan, epratuzumab
What do you think about the features of this website? Take our user survey and have your say:
Next articles:
Tools & Services:
Medical Articles:
Search Specialists by State and City
By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.
Copyright © 2009 Health Grades Inc. All rights reserved.
